Palatin Technologies
PTN
#10051
Rank
A$41.87 M
Marketcap
A$24.60
Share price
-3.99%
Change (1 day)
1,485.52%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$7.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$8.84 Million. In 2024 the company made an earning of -A$40.48 Million, an increase over its 2023 earnings that were of -A$48.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.94 Million-80.4%
2024 -A$40.48 Million-16.9%
2023 -A$48.71 Million5.99%
2022 -A$45.96 Million-13.7%
2021 -A$53.25 Million33.25%
2020 -A$39.97 Million-172.11%
2019 A$55.41 M2352.33%
2018 A$2.25 M-94.13%
2017 A$38.5 M-154.92%
2016 -A$70.11 Million3.67%
2015 -A$67.63 Million878%
2014 -A$6.92 Million-72.64%
2013 -A$25.28 Million-33.11%
2012 -A$37.79 Million77.71%
2011 -A$21.27 Million
2003 -A$36.01 Million29.93%
2002 -A$27.71 Million36.18%
2001 -A$20.35 Million
1999 -A$16.89 Million6.04%
1998 -A$15.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-A$18.04 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$44.31 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.87 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$75.95 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.10 B-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.67 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$83.47 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.66 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK